• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

AMPA拮抗剂2,3-二羟基-6-硝基-7-氨磺酰基-苯并(f)喹喔啉(NBQX)的抗惊厥、抗焦虑及辨别效应

Anticonvulsant, anxiolytic and discriminative effects of the AMPA antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline (NBQX).

作者信息

Swedberg M D, Jacobsen P, Honoré T

机构信息

Novo Nordisk, Pharmaceuticals Division, Malov, Denmark.

出版信息

J Pharmacol Exp Ther. 1995 Sep;274(3):1113-21.

PMID:7562477
Abstract

The anticonvulsant effects of 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline (NBQX), phencyclidine (PCP) and diazepam against audiogenic seizures in DBA/2 mice and against seizures induced by methyl-6,7-dimethoxy-4-ethyl-beta-carboline-3-carboxylate (DMCM) in NMRI mice were compared. Motor impairment was assessed in a rotarod apparatus in DBA/2 as well as NMRI mice. At 30 min after i.p. administration, NBQX was as effective as PCP and diazepam in protecting against audiogenic seizures and had a therapeutic ratio slightly higher than diazepam's and 7-fold higher than PCP's. Whereas diazepam was fully effective, NBQX and PCP were both ineffective against seizures induced by DMCM 30 min after i.p. administration. The anticonvulsant potential and motor-impairing effects of NBQX were evaluated further by the i.p. and the i.v. routes at different time points after administration. At all pretreatment intervals, NBQX protected against audiogenic seizures more potently than it produced motor impairment. NBQX administered i.p. protected against DMCM-induced seizures when given 15 min but not 5 min before testing, whereas after i.v. administration NBQX produced anticonvulsant and motor-impairing effects in the same dose range. NBQX only slightly and non-dose-dependently attenuated the discriminative effects of pentylenetetrazole in rats, showing a limited anxiolytic potential. NBQX produced no PCP-like or morphine-like discriminative effects in rats, suggesting lack of PCP or opiate-like subjective effects. These data demonstrate that NBQX has anticonvulsant effects, has limited anxiolytic effects, and does not produce subjective effects of PCP or opiate type.

摘要

比较了2,3 - 二羟基 - 6 - 硝基 - 7 - 氨磺酰基 - 苯并(f)喹喔啉(NBQX)、苯环利定(PCP)和地西泮对DBA/2小鼠听源性惊厥以及对NMRI小鼠由甲基 - 6,7 - 二甲氧基 - 4 - 乙基 - β - 咔啉 - 3 - 羧酸酯(DMCM)诱导的惊厥的抗惊厥作用。在DBA/2小鼠和NMRI小鼠的转棒试验中评估运动功能损害。腹腔注射给药30分钟后,NBQX在预防听源性惊厥方面与PCP和地西泮效果相当,其治疗指数略高于地西泮,比PCP高7倍。虽然地西泮完全有效,但腹腔注射给药30分钟后,NBQX和PCP对DMCM诱导的惊厥均无效。通过腹腔注射和静脉注射途径在给药后的不同时间点进一步评估了NBQX的抗惊厥潜力和运动损害作用。在所有预处理间隔中,NBQX预防听源性惊厥的效力比其产生运动损害的效力更强。腹腔注射的NBQX在测试前15分钟给药时可预防DMCM诱导的惊厥,但在5分钟前给药则无效,而静脉注射给药后,NBQX在相同剂量范围内产生抗惊厥和运动损害作用。NBQX仅轻微且非剂量依赖性地减弱戊四氮在大鼠中的辨别效应,显示出有限的抗焦虑潜力。NBQX在大鼠中未产生类似PCP或吗啡的辨别效应,表明缺乏PCP或阿片样主观效应。这些数据表明,NBQX具有抗惊厥作用,抗焦虑作用有限,且不产生PCP或阿片类主观效应。

相似文献

1
Anticonvulsant, anxiolytic and discriminative effects of the AMPA antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline (NBQX).AMPA拮抗剂2,3-二羟基-6-硝基-7-氨磺酰基-苯并(f)喹喔啉(NBQX)的抗惊厥、抗焦虑及辨别效应
J Pharmacol Exp Ther. 1995 Sep;274(3):1113-21.
2
YM90K: pharmacological characterization as a selective and potent alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor antagonist.YM90K:作为一种选择性强效α-氨基-3-羟基-5-甲基异恶唑-4-丙酸/海人藻酸受体拮抗剂的药理学特性
J Pharmacol Exp Ther. 1996 Jan;276(1):84-92.
3
LU 73068, a new non-NMDA and glycine/NMDA receptor antagonist: pharmacological characterization and comparison with NBQX and L-701,324 in the kindling model of epilepsy.LU 73068,一种新型非NMDA和甘氨酸/NMDA受体拮抗剂:在癫痫点燃模型中的药理学特性及与NBQX和L-701,324的比较
Br J Pharmacol. 1998 Nov;125(6):1258-66. doi: 10.1038/sj.bjp.0702172.
4
Relief of experimental spasticity and anxiolytic/anticonvulsant actions of the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline.
J Pharmacol Exp Ther. 1992 Feb;260(2):742-7.
5
Effects of the non-NMDA antagonists NBQX and the 2,3-benzodiazepine GYKI 52466 on different seizure types in mice: comparison with diazepam and interactions with flumazenil.非NMDA拮抗剂NBQX和2,3-苯二氮䓬类药物GYKI 52466对小鼠不同癫痫发作类型的影响:与地西泮的比较及与氟马西尼的相互作用
Br J Pharmacol. 1994 Dec;113(4):1349-57. doi: 10.1111/j.1476-5381.1994.tb17146.x.
6
A crucial role of the alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid subtype of glutamate receptors in piriform and perirhinal cortex for the initiation and propagation of limbic motor seizures.谷氨酸受体的α-氨基-3-羟基-5-甲基异恶唑-4-丙酸亚型在梨状皮质和嗅周皮质中对边缘性运动性癫痫发作的起始和传播起着关键作用。
J Pharmacol Exp Ther. 1997 Mar;280(3):1401-5.
7
Some behavioral effects of CNQX AND NBQX, AMPA receptor antagonists.AMPA受体拮抗剂CNQX和NBQX的一些行为效应。
Pol J Pharmacol. 1995 Jul-Aug;47(4):269-77.
8
Anticonvulsant action of 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline in immature rats: comparison with the effects on motor performance.
J Pharmacol Exp Ther. 1997 Jun;281(3):1120-6.
9
Anticonvulsant action of the beta-carboline abecarnil: studies in rodents and baboon, Papio papio.β-咔啉阿贝卡尼的抗惊厥作用:在啮齿动物和狒狒(豚尾狒狒)中的研究
J Pharmacol Exp Ther. 1990 Apr;253(1):344-52.
10
Effects of the AMPA-receptor antagonist, NBQX, on neuron loss in dentate hilus of the hippocampal formation after 8, 10, or 12 min of cerebral ischemia in the rat.AMPA受体拮抗剂NBQX对大鼠脑缺血8、10或12分钟后海马结构齿状回神经元丢失的影响。
J Cereb Blood Flow Metab. 1997 Feb;17(2):147-52. doi: 10.1097/00004647-199702000-00003.

引用本文的文献

1
Kainate Receptor Antagonists: Recent Advances and Therapeutic Perspective.激动型氨基酸受体拮抗剂:最新进展及治疗展望。
Int J Mol Sci. 2023 Jan 18;24(3):1908. doi: 10.3390/ijms24031908.
2
Altered glutamatergic neurotransmission in the striatum regulates ethanol sensitivity and intake in mice lacking ENT1.纹状体中谷氨酸能神经传递的改变调节缺乏 ENT1 的小鼠对乙醇的敏感性和摄入量。
Behav Brain Res. 2010 Apr 2;208(2):636-42. doi: 10.1016/j.bbr.2010.01.011. Epub 2010 Jan 18.
3
In vitro and in vivo studies in rats with LY293558 suggest AMPA/kainate receptor blockade as a novel potential mechanism for the therapeutic treatment of anxiety disorders.
在对大鼠进行的LY293558体外和体内研究表明,AMPA/海人酸受体阻断是治疗焦虑症的一种新型潜在机制。
Psychopharmacology (Berl). 2006 Apr;185(2):240-7. doi: 10.1007/s00213-005-0292-0. Epub 2006 Feb 10.
4
Coantagonism of glutamate receptors and nicotinic acetylcholinergic receptors disrupts fear conditioning and latent inhibition of fear conditioning.谷氨酸受体和烟碱型乙酰胆碱能受体的拮抗作用会破坏恐惧条件反射以及恐惧条件反射的潜伏抑制。
Learn Mem. 2005 Jul-Aug;12(4):389-98. doi: 10.1101/lm.89105.
5
AMPA antagonists differ from NMDA antagonists in their effects on operant DRL and delayed matching to position tasks.α-氨基-3-羟基-5-甲基-4-异恶唑丙酸(AMPA)拮抗剂与N-甲基-D-天冬氨酸(NMDA)拮抗剂在对操作性固定比率间隔(DRL)和延迟位置匹配任务的影响方面存在差异。
Psychopharmacology (Berl). 1996 Aug;126(3):249-59. doi: 10.1007/BF02246455.